Northern Trust Corp Spring Works Therapeutics, Inc. Transaction History

Northern Trust Corp

$658 Billion
Q1 2025

A detailed history of Northern Trust Corp transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 637,446 shares of SWTX stock, worth $29.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

637,446

Previous 655,678 2.78%

Holding current value

$29.5 Million

Previous $23.7 Million 18.75%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$32.5 - $59.93 $592,540 - $1.09 Million	-18,232 Reduced 2.78%	637,446 $28.1 Million
Q4 2024 Feb 14, 2025	BUY	$28.61 - $42.55 $1.51 Million - $2.25 Million	52,908 Added 8.78%	655,678 $23.7 Million
Q3 2024 Nov 13, 2024	BUY	$32.04 - $42.76 $856,204 - $1.14 Million	26,723 Added 4.64%	602,770 $19.3 Million
Q2 2024 Aug 14, 2024	SELL	$36.06 - $47.62 $529,180 - $698,823	-14,675 Reduced 2.48%	576,047 $21.7 Million
Q1 2024 May 14, 2024	SELL	$36.5 - $52.5 $24,090 - $34,650	-660 Reduced 0.11%	590,722 $29.1 Million
Q4 2023 Feb 13, 2024	BUY	$18.94 - $37.24 $1.33 Million - $2.61 Million	70,129 Added 13.45%	591,382 $21.6 Million
Q3 2023 Nov 13, 2023	BUY	$23.12 - $31.38 $465,960 - $632,432	20,154 Added 4.02%	521,253 $12.1 Million
Q2 2023 Aug 11, 2023	BUY	$23.15 - $32.71 $3.71 Million - $5.24 Million	160,119 Added 46.96%	501,099 $13.1 Million
Q1 2023 May 15, 2023	BUY	$24.97 - $34.05 $95,035 - $129,594	3,806 Added 1.13%	340,980 $8.78 Million
Q4 2022 Feb 13, 2023	BUY	$21.73 - $28.72 $623,368 - $823,890	28,687 Added 9.3%	337,174 $8.77 Million
Q3 2022 Nov 14, 2022	BUY	$24.1 - $39.66 $191,980 - $315,931	7,966 Added 2.65%	308,487 $8.8 Million
Q2 2022 Aug 12, 2022	BUY	$18.36 - $60.07 $413,779 - $1.35 Million	22,537 Added 8.11%	300,521 $7.4 Million
Q1 2022 May 13, 2022	SELL	$48.97 - $65.46 $1.15 Million - $1.54 Million	-23,549 Reduced 7.81%	277,984 $15.7 Million
Q4 2021 Feb 08, 2022	BUY	$53.3 - $75.84 $36,990 - $52,632	694 Added 0.23%	301,533 $18.7 Million
Q3 2021 Nov 15, 2021	SELL	$62.66 - $88.26 $1.32 Million - $1.85 Million	-21,009 Reduced 6.53%	300,839 $19.1 Million
Q2 2021 Aug 13, 2021	BUY	$67.45 - $85.63 $1.75 Million - $2.22 Million	25,923 Added 8.76%	321,848 $26.5 Million
Q1 2021 May 12, 2021	SELL	$65.1 - $93.59 $1.71 Million - $2.46 Million	-26,296 Reduced 8.16%	295,925 $21.8 Million
Q4 2020 Feb 11, 2021	BUY	$48.36 - $77.92 $1.33 Million - $2.15 Million	27,574 Added 9.36%	322,221 $23.4 Million
Q3 2020 Nov 16, 2020	BUY	$36.14 - $51.99 $368,591 - $530,246	10,199 Added 3.59%	294,647 $14 Million
Q2 2020 Aug 14, 2020	BUY	$22.98 - $48.57 $3.28 Million - $6.94 Million	142,836 Added 100.86%	284,448 $11.9 Million
Q1 2020 May 14, 2020	BUY	$20.44 - $41.21 $185,165 - $373,321	9,059 Added 6.83%	141,612 $3.82 Million
Q4 2019 Feb 14, 2020	BUY	$17.74 - $39.52 $2.03 Million - $4.52 Million	114,429 Added 631.37%	132,553 $5.1 Million
Q3 2019 Nov 13, 2019	BUY	$18.8 - $27.82 $340,731 - $504,209	18,124 New	18,124 $393,000

Others Institutions Holding SWTX

# of Institutions

361

Shares Held

63.1M

Call Options Held

5.81M

Put Options Held

2.55M

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.89B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Spring Works Therapeutics, Inc. Transaction History